In our networks, the inhibition of RHOA signaling by JK-206 treatment may induce the suppression of Myc targets through downregulation of BIRC5, H2AFZ, HIST1H2BK, KIF15, UBE2S, and FBXO5 in GC cells. This evidence concerns the gene H2AZ1 and gastric cancer.